Literature DB >> 4595313

Activated macrophages and the antitumor action of BCG.

P Alexander.   

Abstract

Mesh：

Substances：

Year:  1973        PMID： 4595313

Source DB:  PubMed          Journal:  Natl Cancer Inst Monogr        ISSN： 0083-1921


× No keyword cloud information.
  6 in total

1.  Adjuvant immunotherapy with BCG in squamous-cell bronchial carcinoma. Immune-reactivity in relation to immunostimulation (preliminary results in a controlled trial).

Authors:  H M Jansen; T H The; G C de Gast; M T Esselink; A M van der Wal; N G Orie
Journal:  Thorax       Date:  1978-08       Impact factor: 9.139

2.  Involvement of T cells in the recall of Salmonella-induced resistance to tumour.

Authors:  M P Ashley; I Kotlarski; D Hardy
Journal:  Immunology       Date:  1977-01       Impact factor: 7.397

3.  Suppression of adjuvant disease by bacillus Calmette-Guérin (BCG).

Authors:  R I Sutherland; F Quagliata
Journal:  Experientia       Date:  1975-03-15

4.  Activity of phagocytic granulocytes in patients with prostatic cancer.

Authors:  R Hofmann; A Lehmer; J Braun; S Bauer
Journal:  Urol Res       Date:  1986

5.  Selective macrophage inhibition abolishes warfarin-induced reduction of metastasis.

Authors:  B Maat
Journal:  Br J Cancer       Date:  1980-02       Impact factor: 7.640

6.  Role of "lymphotoxin" in the local anti-tumour action associated with inflammation caused by delayed hypersensitivity responses or intralesional BCG. I. Variations in response of different syngeneic mouse tumours.

Authors:  I B Parr; L E Jackson; P Alexander
Journal:  Br J Cancer       Date:  1983-09       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.